SMI 998089 / CH0009980894
11’239.83
Pkt
-4.76
Pkt
-0.04%
11.04.2025
| Kurse + Charts + Realtime | Nachrichten | Listen | Info | zugeh. Wertpapiere | |
|---|---|---|---|---|---|
| Snapshot | Chart (gross) | Marktberichte | enthaltene Werte | GV-Termine | Strukturierte Produkte |
| Historisch | Chartvergleich | Analysen | Top/Flop | Dividenden | Trading-Depot |
| Realtime Liste | Realtime Chart (Indikation) | Marktkapitalisierung | |||
Kurse + Charts + Realtime
Nachrichten
Info
zugeh. Wertpapiere
Analysen zu SMI-Werten
| 11.04.25 | Richemont Buy | UBS AG | |
| 11.04.25 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.04.25 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
| 11.04.25 | Givaudan Neutral | UBS AG | |
| 11.04.25 | Givaudan Hold | Deutsche Bank AG | |
| 11.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 11.04.25 | Givaudan Buy | Goldman Sachs Group Inc. | |
| 10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.25 | Zurich Insurance Overweight | Barclays Capital | |
| 10.04.25 | ABB Sell | Deutsche Bank AG | |
| 10.04.25 | UBS Buy | Deutsche Bank AG | |
| 10.04.25 | Swiss Re Overweight | JP Morgan Chase & Co. | |
| 10.04.25 | Givaudan Add | Baader Bank | |
| 10.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 10.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 10.04.25 | Novartis Neutral | UBS AG | |
| 10.04.25 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 09.04.25 | Novartis Neutral | UBS AG | |
| 09.04.25 | UBS Hold | Jefferies & Company Inc. | |
| 09.04.25 | Richemont Hold | Deutsche Bank AG | |
| 08.04.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 08.04.25 | Richemont Buy | Jefferies & Company Inc. | |
| 08.04.25 | UBS Outperform | RBC Capital Markets | |
| 07.04.25 | Roche Buy | UBS AG | |
| 07.04.25 | Novartis Buy | Deutsche Bank AG | |
| 07.04.25 | Givaudan Add | Baader Bank | |
| 07.04.25 | Roche Sell | Deutsche Bank AG | |
| 07.04.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 07.04.25 | Novartis Neutral | JP Morgan Chase & Co. | |
| 04.04.25 | Novartis Buy | Deutsche Bank AG | |
| 04.04.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 04.04.25 | ABB Sector Perform | RBC Capital Markets | |
| 04.04.25 | Givaudan Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Roche Sell | Deutsche Bank AG | |
| 03.04.25 | Richemont Buy | UBS AG | |
| 03.04.25 | Novartis Buy | Deutsche Bank AG | |
| 03.04.25 | Novartis Outperform | Bernstein Research | |
| 03.04.25 | Roche Outperform | Bernstein Research | |
| 03.04.25 | Givaudan Buy | Goldman Sachs Group Inc. |